Zevra Therapeutics (ZVRA) Enterprise Value Growth (5y) (2019 - 2026)
Zevra Therapeutics (ZVRA) Enterprise Value Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.45% |
| Dec 31, 2025 | -114.43% |
| Sep 30, 2025 | -106.86% |
| Jun 30, 2025 | -99.76% |
| Mar 31, 2025 | -92.72% |
| Dec 31, 2024 | -84.89% |
| Sep 30, 2024 | -68.82% |
| Jun 30, 2024 | -46.47% |
| Mar 31, 2024 | -31.44% |
| Dec 31, 2023 | -25.60% |
| Sep 30, 2023 | -27.14% |
| Jun 30, 2023 | 55.74% |
| Mar 31, 2023 | -3.02% |
| Dec 31, 2022 | -9.32% |
| Sep 30, 2022 | -12.71% |
| Jun 30, 2022 | -12.71% |
| Dec 31, 2021 | -16.61% |
| Sep 30, 2021 | -15.66% |
| Jun 30, 2021 | -18.66% |
| Mar 31, 2021 | 7.32% |